Pharma firm claims it can save HSE €144m annually

An Icelandic pharmaceutical firm is expanding into the Irish market, claiming its range of generic drugs could save the health service more than €140 million a year.

Ian Kehoe - avatar

Ian Kehoe

28th March, 2009

An Icelandic pharmaceutical firm is expanding into the Irish market, claiming its range of generic drugs could save the health service more than €140 million a year.

Actavis plans to launch 20 generic drugs in Ireland this year, with the figure rising to 120 within five years, according to Tony Hynds, managing director of Actavis Ireland. The company is spending €2 million on the launch phase and expects to employ2 5 people at its Irish...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago